What Encompass Health Corporation's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 6 | 18 |
| Total trades | 18 | 116 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 116 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Christie Edward M Iii | Director | Oct 19 | Grant / award · A | +221 | $126.63 | +$28K | 9,577 |
| Reidy Christopher R | Director | Oct 19 | Grant / award · A | +284 | $126.89 | +$36K | 18,081 |
| Williams Terrance | Director | Oct 15 | Grant / award · A | +28 | — | — | 16,887 |
| Herman Joan E | Director | Oct 15 | Grant / award · A | +81 | — | — | 49,724 |
| O'Connor Kevin J. | Director | Oct 15 | Grant / award · A | +18 | — | — | 11,600 |
| Hayes Cain A | Director | Oct 15 | Grant / award · A | +4 | — | — | 2,100 |
| Carmichael Greg D | Director | Oct 15 | Grant / award · A | +28 | — | — | 20,377 |
| Katz Leslye G | Director | Oct 15 | Grant / award · A | +81 | — | — | 49,724 |
| Christie Edward M Iii | Director | Oct 15 | Grant / award · A | +11 | — | — | 9,356 |
| Reidy Christopher R | Director | Oct 15 | Grant / award · A | +20 | — | — | 17,797 |
| Schlichting Nancy M | Director | Oct 15 | Grant / award · A | +38 | — | — | 23,010 |
| Price Andrew L | Chief Accounting Officer | Aug 31 | Open-market sale · S | −5,211 | $120.93 | −$630K | 69,483 |
| Darby John Patrick | EVP, Gen Counsel & Secretary | Aug 31 | Open-market sale · S | −4,858 | $121.09 | −$588K | 75,041 |
| Darby John Patrick | EVP, Gen Counsel & Secretary | Aug 31 | Exercise / conversion · M | +4,858 | $35.06 | +$170K | 79,899 |
| Coltharp Douglas E | EVP & Chief Financial Officer | Aug 10 | Open-market sale · S | −18,869 | $125.38 | −$2.37M | 50,508 |
| Tarr Mark J | President & CEO | Aug 10 | Open-market sale · S | −1,579 | $126.06 | −$199K | 267,814 |
| Tarr Mark J | President & CEO | Aug 10 | Open-market sale · S | −171,569 | $125.46 | −$21.5M | 269,393 |
| Darby John Patrick | EVP, Gen Counsel & Secretary | Aug 10 | Open-market sale · S | −8,906 | $125.95 | −$1.12M | 75,041 |
| Christie Edward M Iii | Director | Jul 16 | Grant / award · A | +248 | $112.43 | +$27.9K | 9,345 |
| Reidy Christopher R | Director | Jul 16 | Grant / award · A | +319 | $112.40 | +$35.9K | 17,777 |
Loading...
